Prediagnostic plasma nutrimetabolomics and prostate cancer risk: a nested case-control analysis within the EPIC study.
Almanza-Aguilera, E., Martínez-Huélamo, M., López-Hernández, Y., Guiñón-Fort, D., Guadall, A., Cruz, M., Perez-Cornago, A., Rostgaard-Hansen, A. L., Tjønneland, A., Dahm, C. C., Katzke, V., Schulze, M. B., Masala, G., Agnoli, C., Tumino, R., Ricceri, F., Lasheras, C., Crous-Bou, M., Sánchez, M.-J., Aizpurua-Atxega, A., Guevara, M., Tsilidis, K. K., Chatziioannou, A. C., Weiderpass, E., Travis, R. C., Wishart, D. S., Andrés-Lacueva, C. and Zamora-Ros, R. (2024). Prediagnostic plasma nutrimetabolomics and prostate cancer risk: a nested case-control analysis within the EPIC study. Cancers 16(23): 4116.